Phase 1b Multiple Ascending Doses (MAD) of M5542 in Patients
This early-stage clinical trial is testing a new drug named M5542 in adult patients. The main goal is to find out if the drug is safe and well tolerated when taken in different amounts. In this study, different groups of patients receive slowly increasing doses of M5542. Doctors watch each group very closely before moving to a higher dose. This step-by-step approach helps researchers find the safest and most effective dose for future studies. Taking part involves regular hospital visits, health checks, and blood tests to monitor your safety. Because this is an early-phase trial, the main focus is on drug safety rather than providing a cure. Taking part is completely voluntary, and you can withdraw at any time.
At a glance
What is this study about?
When new medicines are developed, they must go through several testing stages to ensure they are safe for people to take. This study is a Phase 1b trial for a new medicine known as M5542. It is designed for adults diagnosed with a condition referred to as CCI. Researchers want to see how the human body processes the medicine and whether it causes any unwanted side effects.
The trial uses an approach called 'multiple ascending doses'. This means a small group of participants receives a low dose of the drug first. Doctors carefully monitor them to make sure there are no severe side effects. If the low dose is safe, the next group receives a slightly higher dose. This gradual process helps medical experts find the best balance between safety and effectiveness.
Early-stage research like this is vital for medical progress. Without Phase 1 studies, doctors cannot develop new treatments for conditions that currently have limited options. By joining this trial, participants provide valuable information that could help shape future therapies.
Key takeaways
- Phase 1b trial testing the safety and dosing of a new drug called M5542.
- Open to adults aged 18 and over diagnosed with CCI.
- Uses slowly increasing doses to find the safest amount for future studies.
- Requires regular clinic visits and routine health checks.
- Taking part is entirely voluntary, and you can withdraw at any time.
Who may be eligible?
This study is open to adults of any gender who are 18 years of age or older and have been diagnosed with the condition under study (CCI).
Because this is an early trial focusing on safety, participants generally need to meet specific health standards. You may need to have your general organ health, such as liver and kidney function, checked before you can join.
People who are pregnant, breastfeeding, or taking certain other medications may not be able to take part. The trial doctor will review your full medical history to confirm whether the study is a safe fit for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years of age or older?
- Have you been diagnosed with CCI?
- Are you willing to attend regular hospital or clinic appointments?
- Are you able to undergo routine blood and health tests?
- Are you comfortable trying an experimental medicine?
What does participation involve?
If you decide to join, you will first attend a screening visit. The medical team will explain the study, answer your questions, and ask you to sign a consent form. They will then perform standard health checks, such as measuring your blood pressure, checking your heart rhythm, and taking blood samples.
During the study, you will take the study drug M5542 as instructed by the doctors. You will need to attend regular clinic visits so the team can monitor how you feel and run routine safety tests. You may also need to stay in the clinic for observation after taking your dose. The study team will follow up with you after your final dose to ensure you remain well.
Potential risks and benefits
Locations (2)
- —UnverifiedPoland
- —UnverifiedGermany
Common questions
What does 'multiple ascending doses' mean?
It means the study tests the medicine in small groups, starting with a low dose. If that dose is safe, the next group receives a slightly higher dose.
Will taking part cure my condition?
Phase 1 trials primarily test the safety of a drug rather than how well it cures a disease. You should not expect a direct cure.
Do I have to pay to participate?
No, study medicines and trial-related tests are provided free of charge, and travel expenses are often reimbursed.
Can I leave the study if I change my mind?
Yes, taking part is completely voluntary. You can stop at any time without giving a reason, and your usual NHS care will continue as normal.
What happens if I experience side effects?
The medical team monitors you closely throughout the trial. If you feel unwell or have side effects, doctors will provide prompt medical support.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.